Curis, Inc. (CRIS) Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
11/8/2011 7:05:59 AM
LEXINGTON, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced the appointment of Maurizio Voi, M.D., as Chief Medical and Chief Development Officer. Dr. Voi will be responsible for the Company's development, clinical trial and regulatory affairs operations, as well as biomarker and translational medicine activities.